Saturday 19 Sep, 2020 08:42 AM
Site map | Locate Us | Login
   Khandwala Securities Ltd leads losers in 'B' group    Shilpa Medicare gains after board OKs setting up unit in Malaysia    Volumes jump at Essel Propack Ltd counter    Laurus Labs hits record high; adds 26% in ten days    Financials stocks slide    FMCG stocks edge lower    Ramco Systems climbs 33% in six days    Welspun Corp Ltd gains for fifth session    Exide Industries Ltd spurts 0.51%, up for five straight sessions    Dr. Reddy hits record high; gains over 20% in four days    Orient Abrasives Ltd leads gainers in 'B' group    Natco Pharma Ltd leads gainers in 'A' group    Cadila Healthcare surges on USFDA nod for mineral supplement     Lupin, Cipla spurt after Perrigo recalls albuterol sulfate inhalation aerosols    Hindalco firms up on signing pact with Hindustan Copper 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Alembic Pharma raises 750 cr from QIP issue
07-Aug-20   14:40 Hrs IST

Alembic Pharmaceuticals had launched a QIP issue on 3 August 2020 and closed on 5 August 2020. It had set a floor price of Rs 980.75 per equity share for the QIP issue.

Tata Mutual Fund, HDFC Life Insurance Company, Sundaram Mutual Fund, Bajaj Allianz Life Insurance Company and IDFC Mutual Fund were allotted more than 5% of the equity shares offered in the issue.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.

The company reported a 143.7% surge in consolidated net profit to Rs 301.46 crore on 41.4% rise in net sales to Rs 1,341.32 crore in Q1 June 2020 over Q1 June 2019.

The scrip fell 1.92% to Rs 1,060.80 on the BSE. It had jumped 7.60% to end at Rs 1,081.55 yesterday.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 14822130
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd